At The Baker Company, we have been safeguarding you and your work since 1951 and in that time, we have seen many innovations. However, as the global fight against the COVID-19 pandemic continues, The Baker Company’s mission has never been more important!
As always, we are extremely proud to say that we are Supporting Science, including those highly skilled and dedicated individuals who are helping to make our world a safer place during the current fight against COVID-19.
Behind every COVID-19 test result there is a Medical Laboratory Scientist or Technician who plays crucial part in the scientific research required.
Here at Baker, we have been here to support scientists and their discoveries for the last 7 decades and we will continue to #SupportScience worldwide for several more.
A new study is documenting the antiviral immune response to SARS-CoV-2 in a group of 20 adults who had recovered from COVID-19. The findings of the study have shown that the body’s immune system is able to recognize SARS-CoV-2 in numerous ways.
The US Biotech firm Moderna have said that clinical tests of its vaccine against COVID-19 have shown positive interim results, so much so that the company have informed that the Phase-2 trial has already been given the go ahead. They aim to start their Phase-3 study in July.
Excess inflammation in COVID-19 patients is said to be one of the major causes of death. However, there is now a new therapy designed to reduce inflammation which involves injecting lab grown heart cells into patients.
NIH has launched a clinical trial into the study of whether the malaria drug, Hydroxychloroquine combined with antibiotic Azithromycin can prevent hospitalization during COVID-19. With the first person enrolled, the clinical trial has begun San Diego, CA. The NIAID is sponsoring the trial and will aim to evaluate the efficacy of the drugs against the COVID-19.